Abbott
Abbott collaboration launches award to recognise healthcare teams across the world
A new global healthcare award has been created to recognise the clinical care teams dedicated to improving patient care through innovative approaches. more
World's smallest mechanical heart valve gets FDA approval
The FDA has approved the world’s smallest mechanical heart valve designed for mitral or aortic valve replacement in babies and toddlers. more
Heart failure patients show lower rates of stroke thanks to medical device
Heart failure patients at Brigham and Women’s Hospital had lower rates of blood clots and strokes thanks to a new medical device, findings show. more
Can Irish medtech flourish in the Middle East?
With a growing demand for medical technologies all over the world and reports that markets in the east are expected to grow, MPN takes a look at what potential the Irish medtech sector has in the Middle East. more
Five big medical device recalls
MPN takes a look at some the biggest medical device recalls that have taken place over the recent years. more
Learning to trust: should we let our medtech guard down?
In the latest edition of Medical Plastics News, group editor Lu Rahman discusses issues of data security and whether we should trust connected medical devices. more
Glucose self-monitoring system now on prescription across UK & Ireland
Healthcare company Abbott has announced that its FreeStyle Libre sensor is now available on prescription in England, Wales, Northern Ireland & Scotland. more
FDA approved glucose monitor doesn't require finger prick
In a move that’s sure to please adults with diabetes in the US, the FDA has approved a glucose monitoring device that doesn’t require the user to prick themselves for a blood sample. more
Medical manufacturers respond to devastating effects of Hurricane Maria
A number of medical manufacturers based in Puerto Rico have responded to the impact and damage caused by hurricane Maria. more
Automatic glucose monitoring system gets NHS approval
A system designed to automatically measure glucose levels through a sensor has been approved by the NHS and will be available for reimbursement across England, Wales, Scotland and Northern Ireland from 1 November. more
Medical Plastics News: Weekly news roundup
Medical Plastics News takes a look at some of the biggest stories that have emerged over the past week. more
Abbott pacemakers recalled over cyber-security vulnerabilities
Over 500,000 pacemakers developed by medical device maker Abbott have been shown to contain cyber-security issues. more
Abbott’s smartphone compatible cardiac monitor gains CE Mark approval
Healthcare company Abbott has announced that its smartphone compatible Confirm Insertable Cardiac Monitor (ICM) has gained CE Mark approval. more
Abbott responds to FDA warning letter
The Food and Drug Administration (FDA) has warned medical device maker Abbott that it must submit a plan to address any cybersecurity issues and other safety issues identified in cardiac devices from the company’s recently acquired St Jude Medical. more
Abbott hunts for employees
Abbott is aiming to recruit more than 150 people to work at its UK diabetes care manufacturing hub in Witney, Oxfordshire more
Dissolving heart stent gets FDA thumbs up
The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more
Absorbable stents non-inferior to metal, study finds
A drug-eluting coronary stent made of a biodegradable polymer performed similarly to the gold-standard metal one in a non-inferiority trial among patients with the more serious type of heart attack known as ST-segment elevation myocardial infarction more
Positive clinical trial results for dissolving heart stent
Abbott has announced positive one-year clinical results from the Absorb III trial more
Event: Diabetes Professional Care 2015
Diabetes Professional Care 2015 will take place at the Barbican Exhibition Centre in London from 11-12 November more
Abbott completes acquisition of Topera
Done deal: Abbott has completed its acquisition of Topera, a medical device company focused on developing innovative electrophysiology technologies more